Thomas Okarma gave the keynote address at the 2010 World Stem Cell Summit. He spoke about his company’s research and future plans for treating those with spinal injuries. The Geron Corporation had received permission from the FDA to begin the world’s first human clinical trial to test embryonic stem cells as a treatment for spinal cord injuries.
Recent Posts
- NIH Ends Funding for Research Using Human Fetal Tissue
- Mum hails cord blood donation after life-saving transplant
- Stem cell engineering breakthrough paves way for next-generation living drugs
- How genetically modified stem cells could repair the brain after a stroke
- How TikTok can be used to recruit young stem cell donors
- ChatGPT Health and what AI can do for a broken system
